Granules India Limited has informed the Exchange regarding a press release dated December 03, 2020, titled "Granules India Limited announces approval of Penicillamine Capsules, 250 mg, generic equivalent of Cuprimine �� of Bausch Health Americas, Inc.".
Press Release Dec 03 2020
Filed with NSE · · 3 pages · English
Release
Earlier from Granules India
Later from Granules India
- Press Release Jan 13 2021
- Press Release Feb 01 2021
- Press Release Feb 17 2021
- Press Release Feb 24 2021
- Press Release Jul 21 2021
Follow Granules India into a list and get an email when it puts out news.
Follow Granules India